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CLINICAL SCIENCE
Sex Disparity in How Pain Sensitivity Influences Dry Eye
Symptoms
Wing Li, OD, PhD,* and Meng C. Lin, OD, PhD*†
Purpose: Women have a higher dry eye disease prevalence
compared with men, although only relatively minor differences in
the ocular surface have been observed. Interestingly, a sex difference
in pain sensitivity is known, and recent research suggests that pain
sensitivity is associated with dry eye symptoms. This study attempts
to discern whether the association between pain sensitivity and dry
eye symptoms varies between women and men.
Methods: In this prospective cross-sectional study, subjects were
seen for one visit where they were asked to ﬁll out a set of
questionnaires consisting of the Pain Sensitivity Questionnaire,
Ocular Surface Disease Index (OSDI), and other dry eye question-
naires. This was followed by an ocular surface assessment on
both eyes.
Results: Two hundred eighty-seven subjects (194 women, 93
men) completed the study. Intersex differences in the ocular
surface were noted. Even after accounting for these differences,
an interaction effect between sex and Pain Sensitivity
Questionnaire-minor score on dry eye symptoms was observed,
with only women noting increased symptoms on the OSDI (P ,
0.005) and other dry eye questionnaires (P values ranging from
0.01 to ,0.005) with greater pain sensitivity. After controlling
for other variables, women with the highest pain sensitivity had
a 17-point higher OSDI score and greater symptoms, as reported
by all the other dry questionnaires compared with their
male counterparts.
Conclusions: The role of pain sensitivity on dry eye symptoms
appears to vary between women and men. This difference provides
insight into why women have a signiﬁcantly higher dry eye disease
prevalence than men.
Key Words: pain sensitivity, sex, dry eye disease, symptoms, ocular
surface
(Cornea 2019;38:1291–1298)
Evidence suggests that sex is an important risk factor fordry eye disease (DED) because studies have found that
women have a 16% to 300% greater prevalence of DED
compared with men.1,2 Women are also more apt to be
affected by it, reporting a greater reduction in quality of life
and encountering more issues with anxiety and depression
related to their DED.3 It is hypothesized that a major cause
for the disparity in DED prevalence is attributed to the
effects of sex hormones observed, primarily in vitro, on the
ocular surface.1,4 Estrogen is known to promote inﬂamma-
tory processes and inhibit lipogenesis.1 Androgen, which
is found in higher levels in men, and testosterone are
associated with preventing atrophy of the meibomian and
lacrimal glands.1,4 Therefore, it is surprising that most
clinical studies have found no or relatively minor differ-
ences in the ocular surface between women and men.5–7
Given the poor association between signs and symptoms
of DED, it seems unlikely that a relatively minor sex
difference in the ocular surface could satisfactorily explain
the signiﬁcant disparity in DED.8
In trying to formulate an alternate hypothesis
to explain this disparity, it appears worthwhile to draw
on insights from other chronic pain conditions that
are more common in women, such as migraine and
ﬁbromyalgia.9–11 Although there is a complex interaction
of factors responsible for why these conditions are more
common in women, there has been a focus on the fact that
women are likely more pain sensitive than men as
a potentially important cause.9–11 The sex difference in
pain sensitivity is of particular interest because of the
results of recent studies, which have shown that greater
pain sensitivity is associated with higher levels of dry eye
symptoms and ocular surface discomfort.12–14 It should be
noted that the cohorts in these studies primarily consisted
of women, and it is unknown whether there is a sex-
speciﬁc difference in how pain sensitivity inﬂuences
symptoms.12,14
To answer this question, a prospective cross-sectional
study was conducted that included a thorough assessment of
the ocular surface and used the Pain Sensitivity Questionnaire
(PSQ) to quantify pain sensitivity.15,16 The aim of the study
was to determine whether pain sensitivity inﬂuences dry eye
symptoms differently between women and men, while
accounting for any signiﬁcant intersex differences in subject
characteristics and ocular surface parameters. The results of
this study may offer insight on whether a sex difference in
pain sensitivity could, in part, explain the disparity in
DED prevalence.
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MATERIAL AND METHODS
Study Population
For this prospective cross-sectional study, subjects were
recruited during a 2-year period from the University of
California, Berkeley, and the surrounding community for
a one-visit assessment. The study cohort consisted of a diverse
set of individuals, which approximated the population makeup of
the city of Berkeley, CA. Subjects were excluded if they chose
not to discontinue contact lens wear, makeup, artiﬁcial tears, or
facial lotion use for at least 24 hours before their visit. They were
also excluded if they presented with evidence of active ocular
infection or acute inﬂammatory event (eg, uveitis). This study
attempted to recruit a broad population, so no exclusion criteria
were set based on dry eye or contact lens wear status. To ensure
there was no ascertainment or selection bias of dry eye subjects,
no mention of DED, ocular discomfort, or any related terms were
included in the subject recruitment material. Subjects were
deﬁned as noncontact lens wearers if they had never worn
contact lenses or had discontinued contact lens wear more than 1
year before study participation. Because studies have found
marked differences between Asians and non-Asians in DED
prevalence and pain sensitivity, the subjects were asked about
their ethnicity.17 Individuals were considered to be Asian if they
were of Chinese, Taiwanese, Japanese, Vietnamese, or Korean
descent, or a mixture of these ethnicities. Individuals were
considered to be non-Asian if they were of any other ethnicity
(eg, European white, Latin American, African, or Spanish
descent, or a mixture thereof). Written informed consent, with
a complete description of the goals, risks, beneﬁts and procedures
of the study, was obtained from all participants. This study
followed the tenets of the Declaration of Helsinki and was
approved by the University of California, Berkeley, Committee
for Protection of Human Subjects.
Study Protocol
The subjects were administered a battery of question-
naires composed of the Ocular Surface Disease Index
(OSDI), Berkeley Dry Eye Flow Chart (DEFC), Standard-
ized Patient Evaluation of Eye Dryness (SPEED), and 100-
point visual analog rating scales for average daily comfort (0
= “poor comfort, intolerable,” 100 = “excellent comfort”)
and average daily dryness (0 = “no sensation of dryness
whatsoever,” 100 = “extremely dry, intolerable”).18
Although there is a signiﬁcant overlap of symptom assess-
ment in dry eye between the questionnaires, they were
included because they likely provide different dimensions
and insights on the symptoms experienced by the subjects.19
The subjects were also asked to complete the PSQ, which
has been validated in normal and chronic pain populations
and in ocular surface research.12,15,16 Investigators were
masked to the results of these questionnaires.
A comprehensive set of ocular surface assessments was
performed on both eyes, with the test order selected from the
least to the most invasive procedure; the grading criteria used
for assessments in this study are described in more detail in
Table 1. Subjects’ tear ﬁlm lipid layer thickness was measured
using the LipiView interferometer (TearScience Inc, Morris-
ville, NC). Tear meniscus height was then assessed with the
Oculus Keratograph 5M (Oculus Optikgeräte GmbH, Wetziar,
Germany). The noninvasive tear breakup test (NITBUT) was
conducted 3 times for each eye using the Medmont E300
corneal topographer (Medmont International Pty Ltd, Victoria,
Australia), alternating between eyes, with a 30-second break
between each measurement, and an endpoint consisting of the
ﬁrst visible disruption noted on the placido mires.
The subjects were then examined with a slit lamp
(SL120; Carl Zeiss Meditec Inc, Jena, Germany) with white
light only. One microliter of 2% sodium ﬂuorescein was then
applied to each eye using an adjustable-volume micropipette
(Eppendorf, Hamburg, Germany).20 Corneal staining was
assessed under cobalt blue illumination and viewed through
a 530-nm yellow barrier ﬁlter. Corneal staining type, depth,
and extent were evaluated using the Cornea and Contact Lens
Research Unit grading scale.21
One drop of 1% Lissamine Green (Leiter’s Compound-
ing Pharmacy, San Jose, CA) was then applied, and
conjunctival staining was graded using the Sjogren Interna-
tional Collaborative Clinical Alliance grading scale.22 Infra-
red meibography was then conducted on the upper and lower
eyelid using the Oculus Keratograph 5M. In the ﬁnal test, tear
production was measured using Schirmer Strip Test 1
(without anesthesia).
Statistical Methods
The PSQ provides 3 values: the overall pain sensitivity
score (PSQ-total) and scores for sensitivity to minor (PSQ-
min) and moderate (PSQ-mod) pain situations. The PSQ
provides a score that rates pain sensitivity on a scale of 0 to
10, with a higher score associated with greater pain sensitiv-
ity. Our previous study determined that the PSQ-min score
most accurately reﬂected the inﬂuence of pain sensitivity on
dry eye questionnaires.12
Data were analyzed with the R statistical package
(version 3.3.2; R foundation for Statistical Computing, Vienna,
Austria). Aggregate values (ie, summation of values from all
grading zones) for corneal and conjunctival staining were used
for analysis. The use of aggregate values in statistical modeling
TABLE 1. Grading Criteria for Ocular Surface Assessments
Used in the Study
Assessment Grading Criteria
Blepharitis 0: Clear eyelid margin
1: Occasional fragment (scurf), 1–5 collarettes
2: Few fragments, 6–20 collarettes
3: Many fragments, 21–40 collarettes
4. Clumps/strands, .40 collarettes
Corneal staining type21 0: Absent
1: Micropunctate
2: Macropunctate
3: Coalescent macropunctate
4: Patch
Conjunctival staining22 0: 0–9 dots
1: 10–32 dots
2: 33–100 dots
3: .100 dots
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was decided a priori to minimize the possibility of type 1 error
and because our previous studies have noted no-to-minimal
beneﬁts in sectorial analysis.23
The ﬁrst set of statistical analysis was conducted to
identify signiﬁcant intersex differences in subject character-
istics and ocular surface parameters, and was assessed using
Student’s t test, comparison of 2 proportions testing using
Z-test or linear mixed effects model, when appropriate. The
second analysis was to determine whether pain sensitivity and
sex were signiﬁcantly associated with dry eye symptoms. To
accomplish this, a thorough exploratory and descriptive
preliminary analysis was conducted by assessing bivariate
plots to examine for signiﬁcant associations between explan-
atory and outcome variables. Because the primary focus for
the analysis was to determine the role of pain sensitivity on
dry eye symptoms in men and women, the primary explan-
atory variables of interest were PSQ-min score, sex, and their
interaction effect (PSQ-min score:sex). Because subject
characteristics and the ocular surface parameters have been
associated with dry eye symptoms, signiﬁcant intersex differ-
ences noted during the ﬁrst analysis were considered
secondary explanatory variables and included in ﬁnal multi-
variate models to control for their potential confounding
effects on dry eye symptoms. It should be noted that although
these signiﬁcant intersex differences were identiﬁed using
multiple Student t tests, a P value adjustment was not used
because these t tests were not intended to reject a null
hypothesis, but rather to facilitate the development of the
most parsimonious multivariate models.
The possible explanatory variables were PSQ-min
score, sex, their interaction effect (PSQ-min score:sex), and
signiﬁcant intersex differences in subject characteristics and
ocular surface parameters. The decision to only use statisti-
cally signiﬁcant intersex differences in subject characteristic
and the ocular surface parameters in multivariate modeling
was based on 2 reasons, the analysis was primarily meant to
determine the role of pain sensitivity on dry eye symptoms
between men and women but included other statistically
signiﬁcant intersex differences to control for their potential
confounding effects and to maintain a principle of parsimony
TABLE 2. Mean, SD, and Range for Subject and Ocular Surface Characteristics Between Men and Women, and P Value From
Comparing the 2 groups
Men (n = 93) Women (n = 194) P
Age Mean (SD): 30 (15) yrs Mean (SD): 27 (12) yrs 0.07
Range: 18–66 yrs Range: 18–71 yrs
Ethnicity 38% Asian/62% non-Asian 47% Asian/53% non-Asian 0.03
Contact lens wear status 32% contact lens wearers/68%
noncontact lens wearers
55% contact lens Wearers/45%
noncontact lens wearers
,0.005
PSQ-min score Mean (SD): 2.5 (1.2) Mean (SD): 2.8 (1.5) 0.02
Range: 0.3–5.7 Range: 0.3–7.6
OSDI score Mean (SD): 12 (13) Mean (SD): 14 (14) 0.20
Range: 0–70 Range: 0–71
DEFC score Mean (SD): 2.1 (1.4) Mean (SD): 2.7 (1.5) ,0.005
Range: 1.0–5.0 Range: 1.0–5.0
SPEED score Mean (SD): 6 (5) Mean (SD): 7 (5) 0.19
Range: 0–20 Range: 0–22
Average daily comfort Mean (SD): 78 (21) Mean (SD): 77 (22) 0.54
Range: 15–100 Range: 3–100
Average daily dryness Mean (SD): 21 (21) Mean (SD): 28 (26) ,0.005
Range: 0–100 Range: 0–96
Average tear ﬁlm lipid layer thickness Mean (SD): 60 (19) nm Mean (SD): 64 (20) nm 0.02
Range: 24–100 nm Range: 21–100 nm
Blepharitis Mean (SD): 1.3 (1.4) Mean (SD): 1.2 (1.4) 0.22
Range: 0.0–6.0 Range: 0.0–6.0
Corneal staining type (aggregate) Mean (SD): 0.7 (1.1) Mean (SD): 1.1 (1.5) ,0.005
Range: 0.0–9.0 Range: 0.0–10.0
Conjunctival staining (aggregate) Mean (SD): 1.2 (1.8) Mean (SD): 1.7 (2.1) ,0.005
Range: 0.0–7.0 Range: 0.0–12.0
Noninvasive tear breakup time Mean (SD): 13.2 (12.0) s Mean (SD): 11.4 (12.2) 0.01
Range: 0–95.2 s Range: 1.6–110.0 s
Schirmer strip Mean (SD): 18 (10) mm Mean (SD): 17 (10) mm 0.46
Range: 0–35 mm Range: 0–35 mm
Tear meniscus height Mean (SD): 0.27 (0.10) mm Mean (SD): 0.25 (0.08) mm ,0.005
Range: 0.12–0.81 mm Range: 0.09–0.71 mm
Bolded values indicate statistical signiﬁcance, P , 0.05.
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during modeling. The outcome variables were responses to
the dry eye questionnaires. Linear mixed-effects models were
used to account for potential within-subject correlations
related to measurements performed on both eyes. On
examining residual plots, the NITBUT was natural log-
transformed to better approximate normality to meet key
assumptions for statistical modeling. In all statistical tests and
models, the results with P # 0.05 were considered statisti-
cally signiﬁcant. Signiﬁcant intersex differences in subject
characteristics and ocular surface parameters were included in
all models to control for their possible confounding effects
because they have been shown to be associated with dry eye
TABLE 3. Final Multivariate Model Showing the Association of PSQ-min Score, Sex, Interaction Term (PSQ-min Score:Sex), and
Significant Intersex Differences in Subject and Ocular Surface Characteristics With Questionnaire Response, With Coefficients Also
Listed
OSDI DEFC SPEED
Average Daily
Comfort
Average Daily
Dryness
Intercept 19.8 1.9 6.9 67.1 18.1
P , 0.005 P , 0.005 P , 0.005 P , 0.005 P , 0.005
PSQ-min score 21.8 20.08 20.3 2.7 20.5
P = 0.03 P = 0.34 P = 0.08 P = 0.04 P = 0.18
Sex 28.9 20.1 20.2 13.2 21.2
P , 0.005 P = 0.49 P = 0.06 P , 0.005 P = 0.14
PSQ-min score:sex 3.7 0.1 0.3 24.8 1.6
P , 0.005 P = 0.01 P = 0.03 P , 0.005 P = 0.01
ln (NITBUT) 22.0 20.2 21.2 4.6 25.7
P = 0.02 P , 0.005 P , 0.005 P , 0.005 P , 0.005
Tear ﬁlm lipid layer thickness 0.01 0.0001 20.01 0.02 20.03
P = 0.71 P = 0.95 P = 0.39 P = 0.70 P = 0.54
Tear meniscus height 3.7 0.8 4.4 215.1 35.6
P = 0.57 P = 0.20 P = 0.06 P = 0.14 P , 0.005
Ethnicity 21.0 0.03 20.8 0.7 0.89
P = 0.39 P = 0.81 P = 0.07 P = 0.72 P = 0.67
Conjunctival staining 0.7 0.05 0.3 21.2 1.8
P = 0.02 P = 0.05 P = 0.02 P = 0.01 P , 0.005
Corneal staining type (aggregate) 0.1 0.06 20.2 21.3 0.80
P = 0.82 P = 0.14 P = 0.24 P = 0.04 P = 0.28
Contact lens wear status 21.6 1.2 0.4 0.6 4.6
P = 0.18 P , 0.005 P = 0.30 P = 0.76 P = 0.03
Bolded values indicate statistical signiﬁcance, P , 0.05. The arbitrary reference groups for sex, ethnicity, and contact lens wear status were men, non-Asians, and noncontact lens
wearers, respectively.
FIGURE 1. Scatter plot showing the association
between the Pain Sensitivity Questionnaire
(PSQ-min) score and Ocular Surface Disease
Index (OSDI) scores in women (gray points/
line) and in men (black points/lines).
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symptoms.24 Previous studies have extensively assessed the
disparity in dry eye symptoms between men and women
because of an intersex difference in the ocular surface.
Therefore, to minimize redundancy, this analysis focused
only on assessing the possible effects of sex on the relation-
ship between pain sensitivity and dry eye symptoms.
RESULTS
Subject Characteristics
Two hundred eighty-seven subjects completed the
study (194 women, 93 men), providing 574 eyes for analysis.
The study cohort had a mean (SD) age of 28 (13) years with
a range of 18 to 71 years. The mean (SD) PSQ-min score was
2.7 with a range of 0.3 to 7.6. There were 127 subjects of
Asian descent and 160 subjects of non-Asian descent, and
there were 139 contact lens wearers and 148 noncontact lens
wearers. Among the study cohort, 1 subject had cataract
surgery, 3 subjects had refractive surgery, 2 subjects had
strabismus surgery, 3 subjects had laser retinal treatment
associated with retinal hole/detachment, and 5 subjects had
lid surgery. None of the subjects had been diagnosed or
treated for glaucoma. Table 2 shows that women, when
compared with men, were more likely to be Asian (47% vs.
38%, respectively; P = 0.03), wear contact lenses (55% vs.
32%, respectively; P , 0.005), report more dryness on the
visual analog scale (28% vs. 21%, respectively; P , 0.005),
have a greater DEFC (2.7 vs. 2.1, respectively; P , 0.005)
and PSQ-min score (2.8 vs. 2.5, respectively; P = 0.02), and
were borderline younger (27 vs. 30 years old, respectively; P
= 0.07). For the ocular surface parameters, women had
a thicker tear lipid layer (64 vs. 60 nm, respectively; P =
0.02), lower NITBUT (11.4 vs. 13.2 seconds, respectively; P
= 0.01), shorter tear meniscus height (0.25 vs. 0.27 mm,
respectively; P , 0.005), and greater corneal (1.1 vs. 0.7,
respectively; P , 0.005) and conjunctival (1.7 vs. 1.2,
respectively; P , 0.005) staining. Although corneal staining
type, depth, and extent were evaluated, only staining type was
reported and used in statistical analyses because of the
signiﬁcant multicollinearity between type, depth, and
extent,21 and additional analysis (not shown) did not ﬁnd
signiﬁcant differences in modeling when using corneal
staining type, depth, or extent. No difference was noted for
meibomian gland expression quality (P = 0.45) and quantity
(P = 0.97) scores and Schirmer tear test (P = 0.46). Women
had a larger range of PSQ-min scores (0.3–7.6) compared
with men (0.3–5.7).
Multivariate Modeling
During preliminary analysis for multivariate modeling,
evidence of an interaction effect between PSQ-min score and
sex on questionnaire response was noted on bivariate plots
(Figs. 1 and 2). In multivariate modeling (Table 3), even after
accounting for confounding effects of signiﬁcant intersex
differences in the ocular surface, the main effects, PSQ-min
score, and sex were both signiﬁcantly associated with the
OSDI (P = 0.03 and ,0.005, respectively) and average daily
comfort (P = 0.04 and ,0.005, respectively); they were not
associated with the DEFC (P = 0.34 and 0.49, respectively),
SPEED (P = 0.08 and 0.06, respectively), and average daily
dryness (P = 0.18 and 0.14, respectively). The interaction
term of the PSQ-min score and sex variables was signiﬁcantly
associated with the OSDI (P , 0.005), DEFC (P = 0.01),
SPEED (P , 0.005), average daily comfort (P , 0.005), and
average daily dryness (P , 0.005). This meant that in
women, greater pain sensitivity was associated with increased
dry eye symptoms on all questionnaires. In men, greater pain
sensitivity was either not associated with dry eye symptoms
on the DEFC (P = 0.49), SPEED (P = 0.06), and average
daily dryness (P = 0.14) or associated with decreased dry eye
symptoms on the OSDI (P , 0.005) and average daily
comfort (P, 0.005). After controlling for the other variables,
the maximum effect sizes in the models were observed at the
highest PSQ-min scores, where women with the greatest pain
sensitivity (PSQ-min score of 7.6) were estimated to have
greater dry eye symptoms by 17 points on the OSDI, 1 point
on the DEFC, 2 points on the SPEED, 20 points on average
daily comfort, and 13 points on average daily dryness when
compared with men with the greatest pain sensitivity (PSQ-
min score of 5.7).
DISCUSSION
The ﬁndings from this study suggest that there is
a difference in how pain sensitivity inﬂuences dry eye
symptoms between women and men. It was noted that in
women, greater pain sensitivity was found to be associated with
increased dry eye symptoms, whereas in men, depending on the
questionnaire, greater pain sensitivity was either not associated
with dry eye symptoms or associated with decreased dry eye
symptoms. It is important to note that these associations (with
a clinically meaningful effect size) were noted with all
questionnaires administered and were still observed even after
accounting for signiﬁcant intersex differences in ocular surface
and demographics.25
To date, it is difﬁcult to determine whether men truly
have no change or decreased symptoms associated with
greater pain sensitivity because most studies on this topic
consisted of cohorts that were predominantly women.12,14
The higher proportion of women to men found in this study
reﬂects the general recruitment pool that subjects were drawn
upon. The only study that examined this in men was by Galor
et al,13 who found that increased pain sensitivity was
associated with greater symptoms of dry eye. It should be
noted that their cohort was signiﬁcantly older (mean age of 60
years), with a majority of subjects having a mental illness and
taking psychiatric medications, whereas our study consisted
of a younger and healthy cohort. The stark contrast in cohorts
between the 2 studies makes it difﬁcult to directly compare
ﬁndings because age, mental illness, and psychiatric medi-
cations have all been linked to increased pain sensitivity.26,27
However, because of our large sample size, the fact that we
accounted for confounding effects of signiﬁcant intersex
differences in ocular surface and demographics, along with
the strength and consistency observed in our results among all
the dry eye questionnaires, argues that there is likely
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a difference in how pain sensitivity inﬂuences dry eye
symptom between women and men, but additional work
will be needed to better deﬁne this difference. If, as our
study suggests, greater pain sensitivity is found to be more
strongly associated with higher dry eye symptoms in
women, it could help explain why Vehof et al28 found that
women had a signiﬁcantly lower correlation coefﬁcient in
the association between signs and symptoms of DED
compared with men (r = 0.11 vs. r = 0.33, respectively).
Pain sensitivity could potentially be a more signiﬁcant
confounder in the association between signs and symptoms
for women compared with men.
Although a difference in the ocular surface likely exists
between women and men, there is currently limited evidence
to suggest that it explains the disparity in DED prevalence in
a signiﬁcant way.5–7,29 The ﬁndings from this study suggest
that pain sensitivity could potentially play a role in the
disparity, which may be linked to the difference in the pain-
signaling pathway between men and women. Sex hormones
are thought to play a role because estrogen receptors have
been found on corneal nociceptors.30 Estrogens are also
proinﬂammatory factors, and a consequence of increased
inﬂammation is a diminishment in the stimuli threshold
needed for nociceptor activation.10,11 Finally, there is evi-
dence to suggest that the diffuse noxious inhibitory control,
which is an endogenous nociceptor modulator that inhibits
painful stimuli, is less efﬁcacious in women.9 The diffuse
noxious inhibitory control is important because it has been
linked with the risk of developing chronic pain conditions,
with low efﬁcacy associated with ﬁbromyalgia and temporo-
mandibular joint disorder.31 If a sex difference exists in either
the nociceptors or their modulation, it may be of interest
because symptoms of DED are thought to manifest from the
activation of corneal nociceptors through ocular surface
cooling and increased tear ﬁlm osmolarity.32
Because pain is mediated by many factors, it is also
important to consider the role sociocultural factors, which were
not extensively assessed in this study, had in inﬂuencing the
results.33 At this point, it is difﬁcult to determine whether the
ﬁndings are due to underlying sex-speciﬁc differences in pain-
FIGURE 2. Scatter plot showing the association between Pain Sensitivity Questionnaire (PSQ-min) score and (A) UC Berkeley
DEFC, (B) SPEED, (C) average daily comfort, and (D) average daily dryness in women (gray points/line) and in men (black points/
lines). Higher DEFC, SPEED, and average daily dryness scores are associated with greater dry eye symptoms; higher average daily
comfort score is associated with fewer dry eye symptoms.
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processing pathways, sociocultural factors, or a combination of
these 2. Additional investigation would offer further insight on
the role of pain sensitivity in DED and potentially into other
chronic pain conditions that are more common in women. In
some ways, DED may provide an ideal platform for under-
standing the sex difference in pain sensitivity because of the
extensive testing procedures already developed to assess DED
and because of corneal transparency, which allows for
nerve imaging.
A limitation of this study is that although there are
conﬂicting reports on whether a woman’s pain sensitivity is
inﬂuenced by the phase of the menstrual cycle, it would
have been ideal to know the phase of cycle for each
nonmenopausal female subject at the time of the study.34
The study also primarily consisted of young and healthy
subjects, so it is difﬁcult to know whether the results are
applicable to a broader population, and a study using
a more diverse population is warranted. Nevertheless,
having a largely young and healthy population minimizes
the possibility that allodynia or hyperalgesia from noci-
ceptor sensitization inﬂuenced the results, owing to the
extended time it takes to develop.35,36 In addition, com-
pared with an older population, there is a lower risk of
increased pain sensitivity from systemic diseases and
medications.27 Finally, although pain sensitivity is thought
to be an important component of pain perception, consid-
ering other components of pain perception such as pain
threshold, pain catastrophizing, and response to different
types of induced pain stimuli (heat, cold and mechanical)
through quantitative sensory testing would have provided
a more comprehensive understanding on how pain inﬂuen-
ces the symptoms of DED.15,37
Unlike conditions such as hypertension where treatment
success is deﬁned by the reduction in blood pressure, success
with DED is primarily dictated by symptom improvement.38
Therefore, it is interesting to note that pain sensitivity has
been shown to inﬂuence the perception of symptom improve-
ment after medical treatment.39 Tangentially, our ﬁndings
pose a question on whether we should also view symptom
improvement after dry eye treatment differently between
sexes because pain relief provided by opioids has been
shown to differ between women and men.40 This could
potentially have important implications during phase 3
clinical trials for DED treatments because it may be difﬁcult
to truly evaluate symptom improvement without considering
the effect of sex and pain sensitivity on symptomology and
may explain the high failure rate in dry eye clinical trials.12,41
However, because much is still not understood regarding pain
sensitivity and DED, further study is needed to elucidate how
we should factor pain sensitivity in the diagnosis, monitoring,
and treatment of DED.
This study suggests that pain sensitivity, as measured
with the PSQ-min, inﬂuences dry eye symptoms differently
between women and men. In women, greater pain sensitivity
was associated with increased dry eye symptoms, whereas in
men, greater pain sensitivity was either not associated with
symptoms or associated with decreased symptoms. The
results provide an additional explanation for why women
have a signiﬁcantly higher prevalence of DED than men.
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